GlassScriptPhysician profile
Najam Wasty
NPI 1841247343
$5,295.83
in general payments reported to CMS, 2019-2025
27 companies · $883 in 2025
The $883 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $974 · 2020: $360 · 2021: $349 · 2022: $756 · 2023: $934 · 2024: $1,041 · 2025: $883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,857.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,464.58 | 2021-2025 | Symplicity G3, Onyx Frontier, Spiderfx |
| Shockwave Medical, INC | $429.58 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Irhythm Technologies, INC. | $415.62 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $385.05 | 2021-2024 | Rotapro, Comet, Avvigo Guidance System |
| Abiomed | $296.07 | 2019-2024 | Impella |
| Medtronic Vascular, INC. | $251.37 | 2019-2020 | |
| Amgen INC. | $250.33 | 2019-2025 | Repatha, Repatha |
| Bard Peripheral Vascular, INC. | $235.92 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $234.42 | 2019-2024 | |
| Philips North America LLC | $194.40 | 2022-2023 | |
| Cvrx, INC. | $147.48 | 2025 | Barostim Neo System |
| Zoll Circulation INC | $125.99 | 2023-2025 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Cardiovascular Systems INC. | $125.24 | 2019-2020 | |
| Endologix LLC | $112.00 | 2023 | Alto Abdominal Stent Graft System |
| Cardinal Health 200 LLC | $107.62 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $103.28 | 2019-2025 | Dragonfly Opstar, Jeti |
| Siemens Medical Solutions USA, INC. | $95.90 | 2023 | Corpath Imaging System |
| Janssen Pharmaceuticals, INC | $66.58 | 2019-2024 | Xarelto |
| Heartflow, INC. | $57.25 | 2025 | |
| Terumo Medical Corporation | $51.10 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.07 | 2023-2025 | Jardiance |
| Inari Medical, INC. | $27.61 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Avinger INC. | $24.99 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.27 | 2020 | |
| Amarin Pharma, INC. | $14.56 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.96 | 2019 | |
| Cardiva Medical, INC. | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Najam Wasty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.